Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme

By sjmartinez • June 13, 2023

Fleischmann R, Curtis JR, Charles-Schoeman C, Mysler E, Yamaoka K, Richez C, Palac H, Dilley D, Liu J, Strengholt S, Burmester G. Safety profile of upadacitinib in patients at risk of cardiovascular disease: integrated post hoc analysis of the SELECT phase III rheumatoid arthritis clinical programme. Ann Rheum Dis. 2023 Jun 12:ard-2023-223916. doi: 10.1136/ard-2023-223916. Epub ahead of print. PMID: 37308218.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, methotrexate, Publications, Rheumatology, tumor necrosis factor inhibitors

Short-term outcomes of laparoscopic hiatal hernia repair with consecutive transoral incisionless fundoplication (cTIF): a prospective multicenter cohort study

Kolb JM, Canto MI, Parker B, Murray M, Brewer Gutierrez OI, Sharaiha RZ, Samarasena J, Thosani NC, Abu-Dayyeh BK, Janu P, Chang KJ, Nguyen NT.[...]

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer

McGann KC, Woodhouse P, Chen H, Kammer MN, Holmes HM, Lopez C, Pass HI, Tsay JJ, Lenburg ME, Dubinett SM, Willey JC, Herman JG, Schabath[...]

Intersecting Vulnerabilities: Depression, Suicidality, and HIV Risk Among Young Mothers in South Africa

Miller AP, Joseph Davey DL, Groenewald C, Filiatreau LM, Petersen Z, van Rooyen H, Essack Z. Intersecting Vulnerabilities: Depression, Suicidality, and HIV Risk Among Young[...]